KENILWORTH, NJ & MIAMI, FL – Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the New England Journal of Medicine has published… Read More
Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase™ platform gene editors to build a pipeline of treatments for serious genetic diseases. TORONTO, ON – Specific Biologics… Read More
Canada has a strong track record of medical innovation: insulin, stem-cell therapies and HIV drug cocktails all have their origins in this country. However, life-saving innovation has been limited in… Read More
VANCOUVER, BC & SHANGHAI- Virogin Biotech is pleased to announce the closing of its Series D2 round of financing, raising $127 million USD. The financing round was led by China… Read More
VANCOUVER, BC – Variational AI, developer of state-of-the-art generative AI technology to redefine the economics of drug development by accelerating the discovery of novel and optimized small molecule therapeutics, today announced… Read More
